临床试验的进展和隐私.pdf

1、Progress and Privacy in Clinical TrialsWelcome and Introductions(7 mins)Balancing individuals interests in protecting their privacy while driving medical advancement in the clinical trials space.(45 mins)Key challenges presented by country-specific requirementsPractical solutions,with near-term stra

2、tegies for best practices and longer-term strategiesBest practices for data privacy-related contracts and informed consent formsKey challenges and practical solutions for data transfers in the clinical trial spaceEnforcement and litigation risks related to data privacy violationsClosing Remarks(3 mi

3、ns)Questions and Answers(5 mins)AGENDA OUTLINEAmber Gosney,Managing Director,FTI ConsultingWolf-Tassilo Bhm,Counsel,Latham&WatkinsMarta Siemaszko,Global Operations DirectorNovartisWELCOME AND INTRODUCTIONSRESOURCE LISTFTI Technology&IAPP:AI Governance in Practice Report 2024Amber Gosney,Managing Dir

4、ector,FTI C+44 7977 020 279Wolf-Tassilo Bhm,Counsel,Latham&W+49 696 062 6558Marta Siemaszko,Global Operations DirectorN+48 663 874 863Panel contact details:Report:How Did Things Go?(We Really Want To Know)Did you enjoy this session?Is there any way we could make it better?Let us know by filling out a speaker evaluation.1.Open the Cvent Events app.2.Enter IAPP DPC24(case and space sensitive)in search bar.3.Tap Schedule on the bottom navigation bar.4.Find this session.Click Rate this Session within the description.5.Once youve answered all three questions,tap Done.